Lantern Pharma Inc. deeply regrets to announce the death of Dr. Franklyn Prendergast, a director of the Company. The Company learned on October 17, 2023 that Dr. Prendergast had died unexpectedly. Dr. Prendergast had served as a director of the Company since October 2019.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.42 USD | +5.24% |
|
+0.91% | +3.27% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.27% | 47.55M | |
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |
- Stock Market
- Equities
- LTRN Stock
- News Lantern Pharma Inc.
- Lantern Pharma Inc. Announces the Death of Dr. Franklyn Prendergast, a Director of the Company